A recent
report published by Infinium Global Research on chemiluminescence immunoassay
analyzers market provides in-depth analysis of segments and sub-segments in the
global as well as regional chemiluminescence immunoassay analyzers market. The
study also highlights the impact of drivers, restraints, and macro indicators on
the global and regional chemiluminescence immunoassay analyzers market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of global chemiluminescence immunoassay
analyzers market. According to the report, the global chemiluminescence
immunoassay analyzers market is projected to grow at a healthy CAGR over the
forecast period of 2019-2025.
Chemiluminescence
immunoassay form an important segment in diagnostics which majorly deal with
analyzing the antigen-antibody reaction. The spectrum of tests can be analyzed
using this technology are wide and analyzers under this technology form the
backbone of clinical chemistry testing. Chemiluminescence immunoassay analyzer
works on antigen-antibody bonding and forms an immune complex.
Chemiluminescence immunoassay technique uses microplate laminators that
provides sensitive, high throughput and economical way to quantify antigen in
cell lysate, plasma, saliva, urine, culture media sales, and tissue.
Chemiluminescence immunoassay analyzer has multiplex technology that is a
combination of automation, sensitivity, and reproducibility. It has the
capability to run 15 or more assays at the same time. Chemiluminescence
immunoassay analyzers read, analyzes and processes the results quickly, easily
and more cost-effectively than any other analyzers available in the market.
These analyzers are used in hospital and clinical laboratories to run automated
biochemical tests to detect the presence and concentration of substances in the
sales.
The
increasing adoption of advanced technologies for diagnosis and rising
prevalence of endocrine disorder and other chronic diseases are driving the
growth of chemiluminescence immunoassay analyzers market. In clinical
diagnosis, chemiluminescence immunoassay technology is used for diagnosis of
endocrine disorders such as thyroid, diabetes, osteoporosis and many more are
diagnosed by chemiluminescence immunoassay technology. According to American
thyroid association, it is estimated that 20 million Americans suffer from some
of the other thyroid condition during a lifetime. Furthermore,
chemiluminescence immunoassay technology is applied in various fields such as
pharmaceutical analysis, food safety, and environmental monitoring. However,
the high cost of the analytical instrument is a major factor restraining the growth
of chemiluminescence immunoassay analyzers market. Furthermore, the growing
advancements in technology to improve the accuracy of the results is providing
opportunities for the growth of the chemiluminescence immunoassay analyzers
market.
Geographically,
North America is anticipated to hold the dominant position in the global
chemiluminescence immunoassay analyzers market. The rising geriatric population
and developed healthcare sector are driving the growth of this region.
Furthermore, the high rate of adoption of high-technology devices and the
presence of several major device manufacturers and pharmaceutical players
contribute to the growth of the chemiluminescence immunoassay analyzers market.
The Asia Pacific is expected to witness the fastest growth in the forecast
period. The increasing number of chronic diseases, growing adoption of
chemiluminescence immunoassay analyzers in hospitals and diagnostic
laboratories and an expanding pharmaceutical industry is favoring the growth of
the chemiluminescence immunoassay analyzers market.
The report on
global chemiluminescence immunoassay analyzers market covers segments such as
products, application, and end-user. On the basis of products, the sub-markets
include analyzers, reagents, and consumables. On the basis of application, the
sub-markets include endocrine disorders, oncology, infectious diseases,
hepatitis and retrovirus, cardiovascular disorders, allergy, Autoimmunity drug
discovery and development, and other applications. On the basis of end-user,
the sub-markets include hospitals, clinical laboratories, pharmaceutical &
biotechnology industries, and other end-users.
The report
provides profiles of the companies in the market such as F. Hoffmann-La Roche
Ltd, Siemens Healthcare GmbH (Siemens AG), Danaher, Ortho Clinical Diagnostics,
DiaSorin S.p.A., Shenzhen New Industries Biomedical Engineering Co., Ltd., Sysmex
Corporation, Abbott Laboratories, Randox Laboratories Ltd., and Tosoh
Corporation.
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of chemiluminescence immunoassay analyzers
market. Moreover, the study highlights current market trends and provides
forecast from 2019-2025. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.
Please Choose One of them.